modus offers care providers, patients, and payors a complete activity monitoring and assessment solution across multiple high-risk patient groups. These patient segments include those with neurological conditions such as post-stroke, Parkinson's disease, multiple sclerosis and cerebral palsy, as well as those with chronic diseases such as COPD (chronic obstructive pulmonary disease). modus also provides best-in-class eldercare solutions through its unique ability to accurately measure function in users with slow and/or irregular gait.
The rise of wearable sensors and the "quantified self" movement have resulted in heightened interest in activity trackers and similar devices. While gait and activity are key clinical indicators in multiple therapeutic fields, deficiencies in the accuracy of the data from these consumer products significantly limit their utility in actual clinical applications. The challenges of device inaccuracy are especially acute in persons who walk with slow or irregular gait.
modus is uniquely positioned to serve caregivers for these large and challenging patient populations, basing its outcomes platform and analytics on data captured from its StepWatch™ activity monitor. StepWatch™ was created as a research instrument to measure real-world function in the challenging environment of persons using assistive technology to ambulate. Over time, this research expanded to chronic diseases, as well as to large scale pharmaceutical and device trials.
Keywords for this news article include: Technology, modus health.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Shia LaBeouf Plea Deal, Alcoholism Treatment
- Ohio State Band Chief Fired After Probe
- Stop-Start Engines Save Gas, Reduce Emissions
- Hispanic Leader Goes the Extra Mile
- Ukraine Says Russians Firing Across the Border
- Ford Q2 Net Profit up 6 Percent
- U.S. Weighs Refugee Status for Immigrant Kids
- Jennifer Lopez, Pitbull to Perform at Fashion Rocks
- Morgan Stanley Ponies Up $275 Million to Settle SEC Charges
- Ricky Martin Joins 'The Voice ... Mexico'